• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Does HIV pre-exposure prophylaxis use lead to a higher incidence of sexually transmitted infections? A case-crossover study of men who have sex with men in Los Angeles, California.HIV 暴露前预防用药是否会导致性传播感染发病率升高?加利福尼亚州洛杉矶男男性行为者的病例交叉研究。
Sex Transm Infect. 2018 Sep;94(6):457-462. doi: 10.1136/sextrans-2017-053377. Epub 2018 Feb 27.
2
Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.每日用药和按需用药预防方案下男男性行为者的性行为特征和艾滋病毒及性传播感染发病率:AMPrEP 研究两年结果。
Lancet HIV. 2019 Jul;6(7):e447-e455. doi: 10.1016/S2352-3018(19)30136-5. Epub 2019 Jun 6.
3
Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.HIV 暴露前预防与 HIV 感染高危个体性传播感染发病率的关联。
JAMA. 2019 Apr 9;321(14):1380-1390. doi: 10.1001/jama.2019.2947.
4
Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men.男男性行为者中 HIV 暴露前预防措施实施前后性传播感染率趋势的比较。
JAMA Netw Open. 2020 Dec 1;3(12):e2030806. doi: 10.1001/jamanetworkopen.2020.30806.
5
Questioning risk compensation: pre-exposure prophylaxis (PrEP) and sexually transmitted infections among men who have sex with men, capital region of Denmark, 2019 to 2022.质疑风险补偿:丹麦首都地区男男性行为者的 2019 年至 2022 年期间的暴露前预防 (PrEP) 和性传播感染。
Euro Surveill. 2024 Mar;29(13). doi: 10.2807/1560-7917.ES.2024.29.13.2300451.
6
Quantifying heterogeneity in sexual behaviour and distribution of STIs before and after pre-exposure prophylaxis among men who have sex with men.定量评估男男性行为者在暴露前预防措施前后性行为和性传播感染分布的异质性。
Sex Transm Infect. 2022 Sep;98(6):395-400. doi: 10.1136/sextrans-2021-055227. Epub 2021 Oct 29.
7
Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data.澳大利亚全国范围内推广 HIV 暴露前预防(PrEP)后,使用 PrEP 的男同性恋和双性恋男性中细菌性性传播感染发病率的真实世界趋势:哨点监测数据分析。
Lancet Infect Dis. 2022 Aug;22(8):1231-1241. doi: 10.1016/S1473-3099(22)00175-X. Epub 2022 May 25.
8
High HIV incidence in men who have sex with men following an early syphilis diagnosis: is there room for pre-exposure prophylaxis as a prevention strategy?早期梅毒诊断后男男性行为者中高艾滋病毒发病率:暴露前预防作为一种预防策略是否有空间?
Sex Transm Infect. 2017 Aug;93(5):320-322. doi: 10.1136/sextrans-2016-052865. Epub 2016 Oct 19.
9
Incidence of Sexually Transmitted Infections After Initiating HIV Pre-Exposure Prophylaxis Among MSM in Southern Denmark.丹麦南部男男性行为者开始接受艾滋病毒暴露前预防后性传播感染的发生率。
Am J Mens Health. 2021 May-Jun;15(3):15579883211018917. doi: 10.1177/15579883211018917.
10
Sexually Transmitted Infection Screening Among Gay, Bisexual, and Other Men Who Have Sex With Men Prescribed Pre-exposure Prophylaxis in Baltimore City, Maryland.马里兰州巴尔的摩市接受暴露前预防治疗的男同性恋、双性恋和其他与男性发生性关系者的性传播感染筛查。
Clin Infect Dis. 2020 Dec 17;71(10):2637-2644. doi: 10.1093/cid/ciz1145.

引用本文的文献

1
Trends Analysis of Sexually Transmitted Infections Before and After Human Immunodeficiency Virus Pre-exposure Prophylaxis in the United States 2001-2022.2001 - 2022年美国人类免疫缺陷病毒暴露前预防前后性传播感染的趋势分析
Open Forum Infect Dis. 2025 Aug 18;12(9):ofaf491. doi: 10.1093/ofid/ofaf491. eCollection 2025 Sep.
2
Routine Data Analysis of HIV Pre-Exposure Prophylaxis Use and Rates of Sexually Transmitted Infections Since Coverage of HIV Pre-Exposure Prophylaxis by the Statutory Health Insurance in Germany.德国法定健康保险覆盖 HIV 暴露前预防措施后,HIV 暴露前预防措施使用和性传播感染率的常规数据分析。
Arch Sex Behav. 2024 Oct;53(9):3663-3672. doi: 10.1007/s10508-024-02922-5. Epub 2024 Aug 6.
3
Risk of sexually transmitted infections among U.S. military service members in the setting of HIV pre-exposure prophylaxis use.美国军事人员在使用 HIV 暴露前预防措施的情况下,性传播感染的风险。
PLoS One. 2023 Dec 28;18(12):e0296054. doi: 10.1371/journal.pone.0296054. eCollection 2023.
4
HIV pre-exposure prophylaxis and its implementation in the PrEP Impact Trial in England: a pragmatic health technology assessment.HIV 暴露前预防及其在英格兰 PrEP 影响试验中的应用:一项实用的卫生技术评估。
Lancet HIV. 2023 Dec;10(12):e790-e806. doi: 10.1016/S2352-3018(23)00256-4.
5
Challenges and Solutions to STI Control in the Era of HIV and STI Prophylaxis.性传播感染防控面临的挑战与对策:HIV 和性传播感染预防时代的视角
Curr HIV/AIDS Rep. 2023 Oct;20(5):312-319. doi: 10.1007/s11904-023-00666-w. Epub 2023 Sep 26.
6
HIV pre-exposure prophylaxis and diagnoses of sexually transmitted infections - observational data from German checkpoints, 01/2019-08/2021.HIV 暴露前预防和性传播感染诊断 - 来自德国检查站的观察数据,2019 年 1 月至 2021 年 8 月。
BMC Public Health. 2023 Apr 7;23(1):661. doi: 10.1186/s12889-023-15570-6.
7
Regular Testing of HIV and Sexually Transmitted Infections With Self-Collected Samples From Multiple Anatomic Sites to Monitor Sexual Health in Men Who Have Sex With Men: Longitudinal Study.使用来自多个解剖部位的自我采集样本对男男性行为者进行艾滋病毒和性传播感染的定期检测以监测其性健康:纵向研究
JMIR Form Res. 2022 Nov 18;6(11):e40996. doi: 10.2196/40996.
8
HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019.2018 年至 2019 年,在以男男性行为者为主的高感染率人群中,HIV 暴露前预防并未对性传播感染的流行率产生影响,德国。
Euro Surveill. 2022 Apr;27(14). doi: 10.2807/1560-7917.ES.2022.27.14.2100591.
9
Participation, retention and uptake in a multicentre pre-exposure prophylaxis cohort using online, smartphone-compatible data collection.参与、保留和采用基于在线、智能手机兼容的数据收集的多中心暴露前预防队列。
HIV Med. 2022 Feb;23(2):146-158. doi: 10.1111/hiv.13175. Epub 2021 Oct 3.
10
Pre-exposure prophylaxis awareness, acceptability and potential stigma among medical and non-medical clinic staff in methadone treatment settings in northern New Jersey: The key role of non-medical staff in enhancing HIV prevention.在新泽西州北部的美沙酮治疗环境中,医疗和非医疗诊所工作人员对暴露前预防的认识、可接受性和潜在污名:非医疗工作人员在加强艾滋病毒预防方面的关键作用。
J Subst Abuse Treat. 2021 Oct;129:108371. doi: 10.1016/j.jsat.2021.108371. Epub 2021 Mar 17.

本文引用的文献

1
Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.大型综合医疗保健系统中用于预防HIV的暴露前预防:依从性、肾脏安全性及停药情况
J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):540-546. doi: 10.1097/QAI.0000000000001129.
2
Willingness to Take, Use of, and Indications for Pre-exposure Prophylaxis Among Men Who Have Sex With Men-20 US Cities, 2014.2014年美国20个城市男男性行为者对暴露前预防的接受意愿、使用情况及指征
Clin Infect Dis. 2016 Sep 1;63(5):672-7. doi: 10.1093/cid/ciw367. Epub 2016 Jun 9.
3
Pre-exposure Prophylaxis (PrEP) Use, Seroadaptation, and Sexual Behavior Among Men Who Have Sex with Men, San Francisco, 2004-2014.2004 - 2014年旧金山男男性行为者的暴露前预防(PrEP)使用情况、血清适应性及性行为
AIDS Behav. 2016 Dec;20(12):2791-2797. doi: 10.1007/s10461-016-1357-2.
4
HIV providers' likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report.艾滋病病毒(HIV)感染者预防用药(PrEP)的处方可能性因患者类型而异:一份简短报告。
AIDS Care. 2016 Sep;28(9):1154-8. doi: 10.1080/09540121.2016.1153595. Epub 2016 Feb 26.
5
Factors associated with antiretroviral treatment uptake and adherence: a review. Perspectives from Australia, Canada, and the United Kingdom.与抗逆转录病毒治疗接受度和依从性相关的因素:一项综述。来自澳大利亚、加拿大和英国的观点。
AIDS Care. 2015;27(12):1429-38. doi: 10.1080/09540121.2015.1114992. Epub 2015 Dec 7.
6
Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015.生命体征:2015 年美国有指征进行暴露前预防以预防艾滋病毒感染的成年人的估计百分比和人数。
MMWR Morb Mortal Wkly Rep. 2015 Nov 27;64(46):1291-5. doi: 10.15585/mmwr.mm6446a4.
7
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.暴露前预防以预防HIV-1感染(PROUD):一项实用开放标签随机试验试点阶段的有效性结果
Lancet. 2016 Jan 2;387(10013):53-60. doi: 10.1016/S0140-6736(15)00056-2. Epub 2015 Sep 9.
8
No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting.在临床实践环境中,随着艾滋病病毒暴露前预防措施使用的增加,新的艾滋病病毒感染病例未出现增长。
Clin Infect Dis. 2015 Nov 15;61(10):1601-3. doi: 10.1093/cid/civ778. Epub 2015 Sep 1.
9
How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize "Truvada Whores".围绕艾滋病毒暴露前预防用药的污名如何破坏预防和愉悦:呼吁消除对“特鲁瓦达妓女”的污名化
Am J Public Health. 2015 Oct;105(10):1960-4. doi: 10.2105/AJPH.2015.302816. Epub 2015 Aug 13.
10
Healthcare providers' knowledge of, attitudes to and practice of pre-exposure prophylaxis for HIV infection.医疗服务提供者对艾滋病毒感染暴露前预防的了解、态度和实践。
HIV Med. 2016 Feb;17(2):133-42. doi: 10.1111/hiv.12285. Epub 2015 Jul 14.

HIV 暴露前预防用药是否会导致性传播感染发病率升高?加利福尼亚州洛杉矶男男性行为者的病例交叉研究。

Does HIV pre-exposure prophylaxis use lead to a higher incidence of sexually transmitted infections? A case-crossover study of men who have sex with men in Los Angeles, California.

机构信息

David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.

Health and Mental Health Services, Los Angeles LGBT Center, Los Angeles, California, USA.

出版信息

Sex Transm Infect. 2018 Sep;94(6):457-462. doi: 10.1136/sextrans-2017-053377. Epub 2018 Feb 27.

DOI:10.1136/sextrans-2017-053377
PMID:29487172
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6482844/
Abstract

BACKGROUND

Pre-exposure prophylaxis (PrEP) is an effective method for reducing HIV incidence among at-risk populations. However, concerns exist over the potential for an increase in STIs following PrEP initiation. The objective of this study is to compare the STI incidence before and after PrEP initiation within subjects among a cohort of men who have sex with men in Los Angeles, California.

METHODS

The present study used data from patients who initiated PrEP services at the Los Angeles LGBT Center between October 2015 and October 2016 (n=275). A generalised linear mixed model was used with a case-crossover design to determine if there was a significant difference in STIs within subjects 365 days before (before-PrEP period) and 365 days after PrEP initiation (after-PrEP period).

RESULTS

In a generalised linear mixed model, there were no significant differences in urethral gonorrhoea (P=0.95), rectal gonorrhoea (P=0.33), pharyngeal gonorrhoea (P=0.65) or urethral chlamydia (P=0.71) between periods. There were modest increases in rectal chlamydia (rate ratio (RR) 1.83; 95% CI 1.13 to 2.98; P=0.01) and syphilis diagnoses (RR 2.97; 95% CI 1.23 to 7.18; P=0.02).

CONCLUSIONS

There were significant increases in rectal chlamydia and syphilis diagnoses when comparing the periods directly before and after PrEP initiation. However, only 28% of individuals had an increase in STIs between periods. Although risk compensation appears to be present for a segment of PrEP users, the majority of individuals either maintain or decrease their sexual risk following PrEP initiation.

摘要

背景

暴露前预防(PrEP)是降低高危人群中 HIV 发病率的有效方法。然而,人们担心在开始 PrEP 后,性传播感染(STI)的发病率会增加。本研究的目的是比较加利福尼亚州洛杉矶的男男性行为者队列中,在开始 PrEP 前后,同一人群的 STI 发病率。

方法

本研究使用了 2015 年 10 月至 2016 年 10 月期间在洛杉矶 LGBT 中心开始 PrEP 服务的患者数据(n=275)。采用广义线性混合模型和病例交叉设计,确定在开始 PrEP 前 365 天(PrEP 前时期)和开始 PrEP 后 365 天(PrEP 后时期)内,同一人群的 STI 是否存在显著差异。

结果

在广义线性混合模型中,尿道淋病(P=0.95)、直肠淋病(P=0.33)、咽淋病(P=0.65)和尿道衣原体(P=0.71)在两个时期之间无显著差异。直肠衣原体(率比(RR)1.83;95%置信区间 1.13 至 2.98;P=0.01)和梅毒诊断(RR 2.97;95%置信区间 1.23 至 7.18;P=0.02)略有增加。

结论

与 PrEP 开始前后直接比较时,直肠衣原体和梅毒诊断显著增加。然而,只有 28%的个体在两个时期之间 STI 增加。尽管风险补偿似乎存在于 PrEP 用户的一部分中,但大多数个体在开始 PrEP 后要么保持要么减少其性风险。